Cormedix Stock Analysis

CorMedix Stock Analysis Notes

About 40.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 0.8. CorMedix last dividend was issued on the 26th of March 2019. The entity had 1:5 split on the 26th of March 2019. CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey. Cormedix operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 29 people. For more info on CorMedix please contact Joseph MBA at 908 517 9500 or go to https://www.cormedix.com.

CorMedix Investment Alerts

CorMedix Upcoming and Recent Events

CorMedix Largest EPS Surprises

View All Earnings Estimates

CorMedix Environmental, Social, and Governance (ESG) Scores

CorMedix Stock Institutional Investors

Note, although CorMedix's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

CorMedix Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 632.86 M.

CorMedix Profitablity

Management Efficiency

CorMedix has return on total asset (ROA) of (0.3769) % which means that it has lost $0.3769 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6504) %, meaning that it created substantial loss on money invested by shareholders. CorMedix's management efficiency ratios could be used to measure how well CorMedix manages its routine affairs as well as how well it operates its assets and liabilities. As of March 20, 2025, Return On Tangible Assets is expected to decline to -0.53. In addition to that, Return On Capital Employed is expected to decline to -0.84. At present, CorMedix's Other Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Current Assets Total is expected to grow to about 3.2 M, whereas Return On Tangible Assets are forecasted to decline to (0.53).

Technical Drivers

As of the 20th of March, CorMedix shows the Risk Adjusted Performance of 0.0615, downside deviation of 3.93, and Mean Deviation of 3.5. CorMedix technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm CorMedix value at risk, and the relationship between the jensen alpha and semi variance to decide if CorMedix is priced correctly, providing market reflects its regular price of 10.97 per share. Given that CorMedix has jensen alpha of 0.4413, we suggest you to validate CorMedix's prevailing market performance to make sure the company can sustain itself at a future point.

CorMedix Price Movement Analysis

CorMedix Insider Trading Activities

CorMedix Outstanding Bonds

CorMedix Predictive Daily Indicators

CorMedix Corporate Filings

CorMedix Forecast Models

CorMedix's time-series forecasting models are one of many CorMedix's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary CorMedix's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how CorMedix prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling CorMedix shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as CorMedix. By using and applying CorMedix Stock analysis, traders can create a robust methodology for identifying CorMedix entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. CorMedix analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. CorMedix analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

CorMedix stock analysis indicators help investors evaluate how CorMedix stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading CorMedix shares will generate the highest return on investment. By understating and applying CorMedix stock analysis, traders can identify CorMedix position entry and exit signals to maximize returns.

When running CorMedix's price analysis, check to measure CorMedix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CorMedix is operating at the current time. Most of CorMedix's value examination focuses on studying past and present price action to predict the probability of CorMedix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CorMedix's price. Additionally, you may evaluate how the addition of CorMedix to your portfolios can decrease your overall portfolio volatility.